SEC Filing Summary

This filing details a Form 4 filing for Amylyx Pharmaceuticals, Inc. (AMLX) by reporting owner Zeiher Bernhardt G. On June 4, 2026, Zeiher Bernhardt G. was granted 24,372 stock options with a $\$0$ exercise price, vesting on the earlier of June 4, 2027, or the next annual meeting, contingent upon continued service. These options are for the acquisition of Common Stock. The filing indicates that Zeiher Bernhardt G. is a director at Amylyx Pharmaceuticals, Inc. The shares subject to the option will vest in full on the earlier of June 4, 2027 or the date of the next annual meeting, subject to the Reporting Person\'s continuous service to the Issuer through such vesting date. The option has an exercise price of $14.31.